Spruce Biosciences, Inc. (SPRB)
NASDAQ: SPRB · Real-Time Price · USD
45.44
-0.92 (-1.98%)
Jul 15, 2026, 4:00 PM EDT - Market closed
Spruce Biosciences Market Cap
Spruce Biosciences has a market cap or net worth of $125.06 million as of July 16, 2026. Its market cap has increased by 3,984.68% in one year.
Market Cap
125.06M
Enterprise Value
78.11M
1-Year Change
3,984.68%
Ranking
Category
Stock Price
$45.44
Market Cap Chart
Since October 9, 2020, Spruce Biosciences's market cap has decreased from $378.48M to $125.06M, a decrease of -66.96%. That is a compound annual growth rate of -17.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 15, 2026 | 125.06M | 34.13% |
| Dec 31, 2025 | 93.24M | 437.50% |
| Dec 31, 2024 | 17.35M | -85.46% |
| Dec 29, 2023 | 119.28M | 361.35% |
| Dec 30, 2022 | 25.86M | -75.29% |
| Dec 31, 2021 | 104.65M | -81.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cibus | 154.19M |
| TuHURA Biosciences | 152.20M |
| Molecular Partners AG | 150.17M |
| Agenus | 139.50M |
| Unicycive Therapeutics | 139.11M |
| Genelux | 134.56M |
| ProMIS Neurosciences | 127.79M |
| enGene Therapeutics | 127.28M |